These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 11451387

  • 1. Estrogen increases hepatic lipase levels in inbred strains of mice: a possible mechanism for estrogen-dependent lowering of high density lipoprotein.
    Srivastava N, Chowdhury PR, Averna M, Srivastava RA.
    Mol Cell Biochem; 2001 Apr; 220(1-2):87-93. PubMed ID: 11451387
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Estrogen up-regulates apolipoprotein E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway.
    Srivastava RA, Srivastava N, Averna M, Lin RC, Korach KS, Lubahn DB, Schonfeld G.
    J Biol Chem; 1997 Dec 26; 272(52):33360-6. PubMed ID: 9407129
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake.
    Dichek HL, Brecht W, Fan J, Ji ZS, McCormick SP, Akeefe H, Conzo L, Sanan DA, Weisgraber KH, Young SG, Taylor JM, Mahley RW.
    J Biol Chem; 1998 Jan 23; 273(4):1896-903. PubMed ID: 9442022
    [Abstract] [Full Text] [Related]

  • 6. Regulation of the apolipoprotein AIV gene expression by estrogen differs in rat and mouse.
    Srivastava RA, Kitchens RT, Schonfeld G.
    Eur J Biochem; 1994 Jun 01; 222(2):507-14. PubMed ID: 8020488
    [Abstract] [Full Text] [Related]

  • 7. Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism.
    Srivastava RA, Srivastava N, Averna M.
    Eur J Biochem; 2000 Jul 01; 267(13):4272-80. PubMed ID: 10866832
    [Abstract] [Full Text] [Related]

  • 8. Dietary cholate increases plasma levels of apolipoprotein B in mice by posttranscriptional mechanisms.
    Srivastava RA, Averna M, Srivastava N, Pape ME.
    Int J Biochem Cell Biol; 2001 Dec 01; 33(12):1215-26. PubMed ID: 11606258
    [Abstract] [Full Text] [Related]

  • 9. In vivo regulation of apolipoprotein A-I gene expression by estradiol and testosterone occurs by different mechanisms in inbred strains of mice.
    Tang JJ, Srivastava RA, Krul ES, Baumann D, Pfleger BA, Kitchens RT, Schonfeld G.
    J Lipid Res; 1991 Oct 01; 32(10):1571-85. PubMed ID: 1797939
    [Abstract] [Full Text] [Related]

  • 10. Increased apoB100 mRNA in inbred strains of mice by estrogen is caused by decreased RNA editing protein mRNA.
    Srivastava RA.
    Biochem Biophys Res Commun; 1995 Jul 17; 212(2):381-7. PubMed ID: 7626051
    [Abstract] [Full Text] [Related]

  • 11. In vivo regulation of low-density lipoprotein receptors by estrogen differs at the post-transcriptional level in rat and mouse.
    Srivastava RA, Baumann D, Schonfeld G.
    Eur J Biochem; 1993 Sep 01; 216(2):527-38. PubMed ID: 8375391
    [Abstract] [Full Text] [Related]

  • 12. Regulation of the apolipoprotein E by dietary lipids occurs by transcriptional and post-transcriptional mechanisms.
    Srivastava RA.
    Mol Cell Biochem; 1996 Feb 23; 155(2):153-62. PubMed ID: 8700160
    [Abstract] [Full Text] [Related]

  • 13. Apolipoprotein E gene expression is reduced in apolipoprotein A-I transgenic mice.
    Srivastava RA.
    Mol Cell Biochem; 2000 Jun 23; 209(1-2):125-9. PubMed ID: 10942210
    [Abstract] [Full Text] [Related]

  • 14. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
    Zhong S, Goldberg IJ, Bruce C, Rubin E, Breslow JL, Tall A.
    J Clin Invest; 1994 Dec 23; 94(6):2457-67. PubMed ID: 7989603
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females.
    Schaefer EJ, Foster DM, Zech LA, Lindgren FT, Brewer HB, Levy RI.
    J Clin Endocrinol Metab; 1983 Aug 23; 57(2):262-7. PubMed ID: 6408108
    [Abstract] [Full Text] [Related]

  • 18. Severe hypoalphalipoproteinemia in mice expressing human hepatic lipase deficient in binding to heparan sulfate proteoglycan.
    Brown RJ, Gauthier A, Parks RJ, McPherson R, Sparks DL, Schultz JR, Yao Z.
    J Biol Chem; 2004 Oct 08; 279(41):42403-9. PubMed ID: 15292235
    [Abstract] [Full Text] [Related]

  • 19. Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate.
    Brinton EA.
    Arterioscler Thromb Vasc Biol; 1996 Mar 08; 16(3):431-40. PubMed ID: 8630670
    [Abstract] [Full Text] [Related]

  • 20. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice.
    Berti JA, Amaral ME, Boschero AC, Nunes VS, Harada LM, Castilho LN, Oliveira HC.
    Metabolism; 2001 May 08; 50(5):530-6. PubMed ID: 11319713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.